Three firms receive favourable recommendation from SEC on semaglutide formulations: Gireesh Babu, New Delhi Monday, January 19, 2026, 08:00 Hrs [IST] With the patent for Danish dr ...
Contract manufacturer introduces injection device featuring adjustable parameters and streamlined assembly process.
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...
Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...
ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback